SEC Form 4 · accession 0001127602-17-014630
Bioverativ Inc. · BIVV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy Harris Jr.
Officer — EVP, R & D
Period of report
Apr 10, 2017
Accepted (ET)
Apr 11, 2017 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001681689
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock OptionF1 | $56.34 | Apr 10, 2017 | A | 34,556 | A | — | Apr 10, 2027 | Common Stock | 34,556 | 34,556 | D |
| Non-Qualified Stock OptionF2 | $56.34 | Apr 10, 2017 | A | 33,759 | A | — | Apr 10, 2027 | Common Stock | 33,759 | 33,759 | D |
| Restricted Stock UnitsF3,F4 | — | Apr 10, 2017 | A | 11,271 | A | — | — | Common Stock | 11,271 | 11,271 | D |
Explanation of responses
- F1This option vests in full on the second anniversary of the date of grant.
- F2This option vests in two equal annual installments beginning on April 10, 2018.
- F3Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- F4The restricted stock units vest in two equal annual installments beginning on April 10, 2018.